Gelatin-encapsulated digoxin solutions and method of preparing t

Drug – bio-affecting and body treating compositions – Solid synthetic organic polymer as designated organic active... – Polymer from ethylenic monomers only

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424182, 2065247, A61J 307, A61K 948, A61K 31705

Patent

active

040027180

ABSTRACT:
Digoxin solutions are disclosed which are compatible with gelatin and which are of relatively high concentration, thereby permitting encapsulation of therapeutic amounts of digoxin in soft gelatin capsules of moderate size. The digoxin is first micronized and then dissolved in a vehicle consisting predominately of polyethylene glycol having a molecular weight no greater than about one thousand and having a melting temperature no greater than about 35.degree. C., to provide a digoxin concentration of at least one-half milligram per milliliter and preferably one milligram per milliliter. Solutions composed of various solvent blends are disclosed, including solutions which are highly viscous (semi-solid) at room temperature.

REFERENCES:
patent: 2298122 (1942-10-01), Hailer et al.
patent: 2415312 (1947-02-01), Thompson et al.
patent: 2698822 (1955-01-01), Halpern et al.
patent: 2765256 (1956-10-01), Beals et al.
patent: 2780355 (1957-02-01), Palermo et al.
patent: 2860086 (1958-11-01), Stoll et al.
patent: 2889252 (1959-06-01), Valentine et al.
patent: 2899361 (1959-08-01), McMillion
patent: 3139383 (1964-06-01), Neville
patent: 3632742 (1972-01-01), Eckert et al.
patent: 3784684 (1974-01-01), Bossert et al.
patent: 3867521 (1975-02-01), Miskel et al.
Hom et al., J. Pharm. Sci. 59(6):827-830, June 1970, Oral Dosage Form Design and Its Influence on Dissolution Rates for a Series of Drugs.
Shaw et al., Lancet pp. 303-307, Aug. 12, 1972, Variation in the Biological Availability of Digoxin.
Huffman et al., JAMA 222(8):957-960, Absorption of Orally Given Digoxin Preparations.
Lindenbaum, Pharmacol. Rev. 25(2):229-237, June 1973, Bioavailability of Digoxin Tablets.
Huffman et al., Chem. Abst. 78, No. 37853sn(1973), "Absorption of Orally Given Digoxin Preparations."
Lindenbaum et al., Chem. Abst. 79, No. 45722j (1973), "Correlation of Digoxin-Tablet Dissolution Rate with Biological Availability."
Lindenbaum, Chem. Abst. 79, No. 111791j (1973), "Bioavailability of Digoxin Tablets."
Fincher, J. Pharm. Sci. 57(11):1825-1835, Nov. 1968, "Particle Size of Drugs and its Relationship to Absorption and Activity."
Haleblian et al., J. Pharm. Sci. 58(8):911-929, Aug. 1969, "Pharmaceutical Applications of Polymorphism."

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Gelatin-encapsulated digoxin solutions and method of preparing t does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Gelatin-encapsulated digoxin solutions and method of preparing t, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gelatin-encapsulated digoxin solutions and method of preparing t will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1743633

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.